Related Experiment Video
Updated: Jan 21, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Alternative mRNA splicing in cancer immunotherapy
Luke Frankiw1, David Baltimore2, Guideng Li3,4
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Abstract:
Immunotherapies are yielding effective treatments for several previously untreatable cancers. Still, the identification of suitable antigens specific to the tumour that can be targets for cancer vaccines and T cell therapies is a challenge. Alternative processing of mRNA, a phenomenon that has been shown to alter the proteomic diversity of many cancers, may offer the potential of a broadened target space. Here, we discuss the promise of analysing mRNA processing events in cancer cells, with an emphasis on mRNA splicing, for the identification of potential new targets for cancer immunotherapy. Further, we highlight the challenges that must be overcome for this new avenue to have clinical applicability.
Insights
Alternative messenger RNA (mRNA) processing in cancer cells offers new targets for cancer immunotherapies. Analyzing mRNA splicing events can broaden the scope of cancer vaccines and T cell therapies for better treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Cancer immunotherapies show promise for treating previously untreatable cancers.
- Identifying tumor-specific antigens for cancer vaccines and T cell therapies remains a significant challenge.
Purpose of the Study:
- To explore the potential of analyzing messenger RNA (mRNA) processing events in cancer cells as a source of novel immunotherapy targets.
- To emphasize the role of mRNA splicing in expanding the target space for cancer immunotherapy.
Main Methods:
- Review and discussion of current research on mRNA processing in cancer.
- Focus on the analysis of alternative mRNA splicing events.
- Evaluation of the potential for clinical application of identified targets.
Main Results:
- Alternative mRNA processing, particularly splicing, alters cancer proteomic diversity.
- This phenomenon presents a potential for a broader range of targets for immunotherapy.
Conclusions:
- Analyzing mRNA splicing in cancer holds promise for identifying new targets for cancer immunotherapy.
- Overcoming current challenges is crucial for the clinical applicability of this approach.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Pre-mRNA Processing: RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
RNA Splicing
Nuclear Export of mRNA

